Townsend & Associates’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.3M | Sell |
9,246
-26
| -0.3% | -$6.06K | 0.2% | 56 |
|
|
2026
Q1 | $2.1M | Sell |
9,272
-234
| -2% | -$54.5K | 0.18% | 58 |
|
|
2025
Q4 | $2.09M | Buy |
9,506
+104
| +1% | +$20.6K | 0.19% | 57 |
|
|
2025
Q3 | $1.82M | Sell |
9,402
-313
| -3% | -$53.6K | 0.17% | 57 |
|
|
2025
Q2 | $1.64M | Hold |
9,715
| – | – | 0.16% | 59 |
|
|
2025
Q1 | $1.52M | Sell |
9,715
-270
| -3% | -$42.2K | 0.16% | 59 |
|
|
2024
Q4 | $1.48M | Hold |
9,985
| – | – | 0.15% | 58 |
|
|
2024
Q3 | $1.66M | Sell |
9,985
-212
| -2% | -$33.8K | 0.17% | 57 |
|
|
2024
Q2 | $1.64M | Buy |
10,197
+2,502
| +33% | +$372K | 0.18% | 55 |
|
|
2024
Q1 | $1.15M | Sell |
7,695
-95
| -1% | -$15.1K | 0.13% | 59 |
|
|
2023
Q4 | $1.24M | Sell |
7,790
-102
| -1% | -$15.6K | 0.16% | 59 |
|
|
2023
Q3 | $1.15M | Buy |
7,892
+2
| +0% | +$330 | 0.24% | 58 |
|
|
2023
Q2 | $1.36M | Buy |
7,890
+462
| +6% | +$74.6K | 0.35% | 63 |
|
|
2023
Q1 | $1.22M | Buy |
7,428
+5,930
| +396% | +$958K | 0.49% | 66 |
|
|
2022
Q4 | $244K | Buy |
1,498
+2
| +0.1% | +$345 | 0.12% | 95 |
|
|
2022
Q3 | $260K | Buy |
+1,496
| New | +$253K | 0.12% | 74 |
|
|
2021
Q2 | – | Sell |
-8,436
| Closed | -$1.39M | – | 69 |
|
|
2021
Q1 | $1.39M | Sell |
8,436
-189
| -2% | -$30.6K | 0.9% | 48 |
|
|
2020
Q4 | $1.36M | Sell |
8,625
-562
| -6% | -$82.9K | 0.99% | 48 |
|
|
2020
Q3 | $1.39M | Sell |
9,187
-4,610
| -33% | -$682K | 1.09% | 50 |
|
|
2020
Q2 | $1.94M | Sell |
13,797
-1,835
| -12% | -$267K | 1.63% | 14 |
|
|
2020
Q1 | $2.15M | Sell |
15,632
-61
| -0.4% | -$8.65K | 2.23% | 4 |
|
|
2019
Q4 | $2.27M | Sell |
15,693
-427
| -3% | -$57.9K | 1.99% | 7 |
|
|
2019
Q3 | $2.13M | Buy |
16,120
+29
| +0.2% | +$3.82K | 2.03% | 10 |
|
|
2019
Q2 | $2.29M | Sell |
16,091
-68
| -0.4% | -$9.41K | 1.74% | 15 |
|
|
2019
Q1 | $2.26M | Sell |
16,159
-158
| -1% | -$21.2K | 2.28% | 10 |
|
|
2018
Q4 | $2.11M | Buy |
16,317
+345
| +2% | +$48.1K | 2.41% | 10 |
|
|
2018
Q3 | $2.21M | Buy |
15,972
+203
| +1% | +$27K | 2.18% | 12 |
|
|
2018
Q2 | $1.91M | Buy |
15,769
+31
| +0.2% | +$3.87K | 2.15% | 18 |
|
|
2018
Q1 | $2.02M | Buy |
15,738
+2,987
| +23% | +$404K | 1.61% | 19 |
|
|
2017
Q4 | $1.78M | Buy |
+12,751
| New | +$1.78M | 1.52% | 18 |
|
Other funds holding JNJ
Townsend & Associates's JNJ Position: Q2 2026 in Review
Townsend & Associates reduced its Johnson & Johnson (JNJ) stake by 0.28% in Q2 2026, selling an estimated $6.06K and leaving 9,246 shares worth $2.3M. The position accounts for 0.2% of the portfolio, ranked #56.
Townsend & Associates first reported a position in JNJ in Q4 2017 and has held it in 30 quarters since. 4,686 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Townsend & Associates held 9,246 shares of Johnson & Johnson worth $2.3M as of Q2 2026.
- Townsend & Associates sold 26 Johnson & Johnson shares in Q2 2026, an estimated $6.06K.
- Johnson & Johnson made up 0.2% of Townsend & Associates's portfolio in Q2 2026, its #56 holding.
- Townsend & Associates first reported a position in Johnson & Johnson in Q4 2017 and has held it in 30 quarters since.
- 4,686 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Townsend & Associates's 13F filing for Q2 2026, filed 22 Jul 2026.